Representatives from Bengal Laboratories attended a regulatory compliance workshop organized by the Directorate General of Drug Administration (DGDA), focused on updated labeling and registration guidelines for traditional medicine manufacturers.
The workshop reinforced the company’s ongoing commitment to full regulatory compliance across its 45-product Unani portfolio, all of which carry valid D.A.R registration numbers.
Bengal Laboratories continues to work closely with DGDA to ensure its products meet evolving national standards for traditional and complementary medicine.